The Fund's aim is to invest primarily in the equity of companies domiciled in Europe or with significant European activities.
Name | % Net Assets |
---|---|
Nestle S.A. | 5.9% |
GlaxoSmithKline PLC | 4.5% |
Novartis AG | 4.4% |
BASF SE | 4.2% |
Schneider Electric S.A. | 3.4% |
SGS S.A. | 3.1% |
Red Electrica Corp. S.A. | 3.1% |
Metro AG | 3.0% |
Edenred | 3.0% |
Kabel Deutschland Holding AG | 2.9% |
Key | % Net Assets |
---|---|
Nestle S.A. | 5.9% |
GlaxoSmithKline PLC | 4.5% |
Novartis AG | 4.4% |
BASF SE | 4.2% |
Other | 81% |
Date | 05-Oct-2018 |
---|---|
NAV | 89.14p |
Currency | GBP |
Change | 89.14p |
% | n/a |
YTD change | 89.14p |
YTD % | n/a |
Fund Inception | 08/05/2006 |
---|---|
Fund Manager | Chris White |
TER | 1.77 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research